The Citizen1d
Erectile Dysfunction: A rising concern among Tanzania's youth
An investigation by The Citizen’s sister newspaper Mwananchi revealed that the most commonly used drugs are not originally ...
Business Weekly5d
History beckons as Healx doses first rare cancer patient with AI-created drug
Cambridge biotech Healx stands on the cusp of history after dosing the first patient with a rare and deadly cancer with a ...
GEN4d
Healx Candidate, SpringWorks Therapy Expand NF1 Treatment Options
Healx has dosed the first patient in a Phase II trial assessing its lead pipeline candidate HLX-1502 in patients with neurofibromatosis type 1 (NF1), while the FDA approved SpringWorks Therapeutics’ ...